Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while ...

Enrollment in a patient-delivered intervention allowed adults with overweight or obesity to better maintain weight loss than ...

Morgan Stanley increased the price target on Ulta Beauty, Inc. (NASDAQ:ULTA) from $460 to $550 and maintained its Overweight ...

On May 27, Barclays raised the firm’s price target on The Gap Inc. (NYSE: GAP) to $33 from $26 and kept an Overweight rating ...

On Thursday, Morgan Stanley lifted NVIDIA Corporation (NASDAQ:NVDA)’s stock price target to $170 from $160, while maintaining an Overweight rating for its shares. A close-up of a colorful high ...

Morgan Stanley has decided to maintain its Overweight rating of S&P Global (NYSE:SPGI) and lower its price target from $401.00 to $398.00. Shares of S&P Global are trading up 0.17% over the last ...

The firm, which notes that its estimates are “modestly below the Street” in Q2 and 2025, but views the 38% discount to book value as “an attractive entry-point,” remains Overweight-rated ...

Piper Sandler lifted the price target on NVIDIA Corporation (NASDAQ:NVDA) stock from $150 to $180, reaffirming its Overweight ...

On Thursday, Wells Fargo analysts, led by Aaron Rakers, maintained an Overweight rating on NVIDIA (NASDAQ: NVDA) shares, holding steady with a $185.00 price target.Rakers provided insight into ...

On Wednesday, Barclays reiterated an Overweight rating on HealthEquity, Inc. (NASDAQ:HQY) with a price target of $104.00. This affirmation follows the company's fourth-quarter results, which ...

Keybanc has decided to maintain its Overweight rating of Walt Disney (NYSE:DIS) and lower its price target from $216.00 to $151.00. Shares of Walt Disney are trading down 1.92% over the last 24 ...

On May 27, Barclays raised its price target on Iron Mountain Incorporated (NYSE:IRM) to $121 from $118 and maintained an Overweight rating. The rating update came with the firm’s update of ...